Summary[1] edit edit source
BenevolentAI société anonyme operates as a clinical-stage AI-enabled drug discovery company. The company's BenevolentAI platform powers a pipeline of approximately 20 drug programmes. It has collaborations with AstraZeneca, as well as research and charitable institutions. The company is headquartered in London, the United Kingdom.
References and notes edit edit source
- ↑ Source: Yahoo Finance.